Substance: boldenone undecylenate
Brand: Alpha Pharma
Package: 10 ampoules (250mg/ml)


Alpha Pharma has created Boldebolin to be an injectable steroid with very high anabolic and androgenic activity, making it a very long-lasting option for athletes. With its low hepatotoxicity and aromatization, it is ideal for beginners trying injectables for the first time. Also known as Equipoise, the drug's main active ingredient is boldenone undecylenate.

Boldenone Effects

Primarily used by athletes looking to build muscle mass during their cycle, it can also be used to dry off, but generally not to dry off before competition. Due to the increased appetite you get from using the drug, it can be difficult to maintain a proper diet, so it is generally better for mass gain cycles. Other effects are increased strength and hormonal balance.

This is one of the weaker forms of steroids that does not show the same drastic results as some of its injectable counterparts, however it is great for consistent results with minimal side effects.

Equipoise Application and Dosage

Boldenone has a weekly dosage recommendation of 250-750 mg in one or two injections per week, depending on the dose. A cycle lasts 8 weeks and is ideally combined with a long ester of testosterone. Some of these include Enanthate, Cypionate, and Sustanon as great options to combine.

For more experienced weightlifters and bodybuilders Boldenone can be combined with Testosterone itself and with other anabolic steroids such as Methandienone, Anadrol or Turinabol taken orally. In the case of combining with these, the dose of boldenone will be between 600-1000mg per week.

Depending on the individual goals of the athlete, some other possible options for combining a cycle are Primobolan, Testosterone Propionate, Oxandrolone, Trenbolone, and Nandrolone Decanoate.

Additional Information


boldenone undecylenate


10 ampoules (250mg/ml)


Alpha Pharma


There are no reviews yet.

Be the first to review “Boldebolin”

Your email address will not be published. Required fields are marked *